We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current DTIL market cap is 38.2M. The company's latest EPS is USD -7.9936 and P/E is -0.64.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.12M | 7.04M | 17.58M | 49.9M | 576k |
| Operating Income | 4.31M | -15.76M | -2.47M | 23.2M | -22.15M |
| Net Income | -8.08M | -16.29M | 8.59M | 32.75M | -16.43M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 22.24M | 24.29M | 115.53M | 25.1M | 48.73M |
| Operating Income | -87.2M | -109.83M | -39.22M | -102.55M | -48.67M |
| Net Income | -92.88M | -109.01M | -30.6M | -111.64M | -61.32M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 164.34M | 159.78M | 184.74M | 165.8M | 153.26M |
| Total Liabilities | 135.28M | 140.92M | 147.54M | 91.09M | 88.39M |
| Total Equity | 29.06M | 18.86M | 37.21M | 74.71M | 64.87M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 235.23M | 150.16M | 211.5M | 238.17M | 159.78M |
| Total Liabilities | 96.92M | 105.73M | 120.33M | 177.74M | 140.92M |
| Total Equity | 138.31M | 44.43M | 91.17M | 60.43M | 18.86M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -75.69M | -84.11M | -18.98M | -33.85M | -39.76M |
| Investing | 5.79M | 5.83M | -26k | -54k | -118k |
| Financing | 2.56M | 5.39M | 40.1M | 40.8M | 44.53M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -71.02M | -87.39M | -10.85M | -45.75M | -84.11M |
| Investing | -24.67M | -5.03M | -5.8M | -3.32M | 5.83M |
| Financing | 173.37M | 1.33M | 70.52M | 94.99M | 5.39M |
| Market Cap | 38.2M |
| Price to Earnings Ratio | -0.64 |
| Price to Sales Ratio | 0.8 |
| Price to Cash Ratio | 0.33 |
| Price to Book Ratio | 2.07 |
| Dividend Yield | - |
| Shares Outstanding | 7.67M |
| Average Volume (1 week) | 240.01k |
| Average Volume (1 Month) | 1.51M |
| 52 Week Change | -55.63% |
| 52 Week High | 19.4299 |
| 52 Week Low | 3.61 |
| Spread (Intraday) | 0.39 (7.53%) |
| Company Name | Precision BioSciences Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.precisionbiosciences.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
